Proteome Sciences plc provided revenue guidance for 2013. For the year, revenue expected to show a significant increase over 2012 resulting from the strong performance across core activities.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.6 GBX | 0.00% | -10.00% | -20.53% |
05-16 | Proteome Sciences promises AGM return to growth in 2024 | AN |
05-16 | AIM WINNERS & LOSERS: Proteome Sciences eyes return to growth in 2024 | AN |
1st Jan change | Capi. | |
---|---|---|
-20.53% | 13.52M | |
-5.06% | 182B | |
+0.18% | 114B | |
-5.60% | 67.76B | |
+3.90% | 51.91B | |
+7.18% | 43.23B | |
+6.07% | 41.07B | |
+23.33% | 32.07B | |
+15.86% | 25B | |
-2.76% | 24.55B |
- Stock Market
- Equities
- PRM Stock
- News Proteome Sciences plc
- Proteome Sciences plc Provides Revenue Guidance for 2013